|4Mar 17, 9:26 PM ET

Burkhart Erin 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 17, 2023

Insider Transaction Report

Form 4
Period: 2023-03-15
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2023-03-15+3,76014,890 total
  • Award

    Stock Option (Right to buy Common Stock)

    2023-03-15+5,7205,720 total
    Exercise: $87.74From: 2024-03-15Exp: 2033-03-14Common Stock (5,720 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on March 15, 2023. Price not applicable.
  • [F2]Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4